One hundred and ninety non-lactating, pregnant beef cows (¾ Bos taurus and ¼ Bos indicus; 138 multiparous and 52 primiparous) were assigned to this experiment at 117 ± 2.2 d of gestation (d 0). Cows were ranked by parity, pregnancy type (artificial insemination = 102, natural service = 88), body weight (BW) and body condition score (BCS), and assigned to receive a supplement containing: 1) sulfate sources of Cu, Co, Mn, and Zn (INR; n = 95) or 2) an organic complexed source of Cu, Mn, Co, and Zn (AAC; Availa®4; Zinpro Corporation, Eden Prairie, MN; n = 95). The INR and AAC provided the same daily amount of Cu, Co, Mn, and Zn, based on 7 g of the AAC source. From d 0 to calving, cows were maintained in a single pasture and were segregated three times weekly into 1 of 24 individual feeding pens to receive treatments. Cow BW and BCS were recorded on d -30, d 97, upon calving, and at weaning (d 367). Milk production was estimated at 42 ± 0.5 d postpartum via weigh-suckle-weigh (WSW). Liver biopsies were performed in 30 cows/treatment on d -30, 97, upon calving, and the day after WSW. Calf BW was recorded at birth and weaning. Liver and longissimus muscle (LM) biopsies were performed in 30 calves/treatment upon calving and 24 h later, the day after WSW, and at weaning. No treatment effects were detected (P ≥ 0.49) for cow BCS during gestation, despite AAC cows having greater (P = 0.04) BW on d 97. Liver Co concentrations were greater (P < 0.01) for AAC compared to INR cows, and liver concentrations of Cu were greater (P = 0.02) for INR compared to AAC cows on d 97. Upon calving, INR cows had greater (P ≤ 0.01) liver Cu and Zn concentrations compared to AAC cows. No other treatment differences were noted (P ≥ 0.17) for cow and calf liver trace mineral concentrations. Cows receiving AAC had greater (P = 0.04) hepatic mRNA expression of metallothionein 1A at calving, and their calves had greater (P = 0.04) hepatic mRNA expression of superoxide dismutase at weaning. Milk production did not differ between AAC and INR cows (P = 0.70). No treatment effects were detected (P ≥ 0.29) for mRNA expression of LM genes associated with adipogenic or muscle development activities in calves at birth and weaning. Calf birth and weaning BW also did not differ (P ≥ 0.19) between treatments. In summary, supplementing Co, Cu, Zn, and Mn as organic complexed or sulfate sources to beef cows during the last 5 mo of gestation yielded similar cow-calf productive responses until weaning.
This experiment compared performance and physiological responses of the offspring from cows supplemented with Ca salts of soybean oil (CSSO) or prilled saturated fat (CON) during late gestation. Non-lactating, pregnant Angus × Hereford cows (n = 104) that conceived during the same fixed-time artificial insemination protocol, using semen from 2 sires, were used in this experiment. Cows were ranked by pregnancy sire, body weight (BW), and body condition score (BCS). On d 180 of gestation (d -15), cows were randomly assigned to receive (dry matter basis) 415 g of soybean meal per cow daily in addition to 1) 195 g/cow daily of CSSO (n = 52) or 2) 170 g/cow daily of CON (n = 52). Cows were maintained in 2 pastures (26 cows/treatment per pasture), and received daily 12.7 kg/cow (dry matter basis) of grass-alfalfa hay. From d 0 until calving, cows were segregated into 1 of 24 feeding pens thrice weekly and received treatments individually. Cow BW and BCS were recorded, and blood samples were collected on d -15 of the experiment and within 12 h after calving. Calf BW was also recorded and blood sample collected within 12 h of calving. Calves were weaned on d 290 of the experiment, preconditioned for 35 d (d 291 to 325), and transferred to a feedyard where they remained until slaughter. Upon calving, CSSO cows and calves had greater (P < 0.01) plasma concentrations of linoleic acid and total ω - 6 FA compared with CON cohorts. No differences in calf birth BW, weaning BW, and final preconditioning BW were noted (P ≥ 0.36) between treatments. Average daily gain and final BW in the feedlot were greater (P ≤ 0.05) in steers from CSSO cows compared with CON. The incidence of calves diagnosed with BRD that required a second antimicrobial treatment was less (P = 0.03) in calves from CSSO cows, resulting in reduced (P = 0.05) need of treatments to regain health compared with CON (Table 5). Upon slaughter, longissimus muscle area was greater (P = 0.03) in calves from CSSO cows compared with CON. Collectively, these results suggest that supplementing CSSO to late-gestating beef cows stimulated programming effects on postnatal offspring growth and Page 2 of 15 For Peer Review health. Therefore, supplementing late-gestating beef cows with CSSO appears to optimize offspring welfare and productivity in beef production systems.
This experiment compared performance and physiological responses of the offspring from cows supplemented with Ca salts of soybean oil (CSSO) or prilled saturated fat (CON) during late-gestation. Non-lactating, pregnant, multiparous Angus × Hereford cows (n = 104) that conceived during the same fixed-time artificial insemination protocol were assigned to this experiment. Cows were ranked by pregnancy sire (1 of 2 sires), body weight (BW), and body condition score (BCS) on d -15 of the experiment (d 180 of gestation). Cows were then assigned to receive (dry matter basis) 415 g of soybean meal per cow daily in addition to: 1) 195 g/cow daily of CSSO (n = 52) or 2) 170 g/cow daily of CON (n = 52). Cows were maintained in 2 pastures (26 cows/treatment per pasture), and received daily 12.7 kg/cow (dry matter basis) of grass-alfalfa hay from d -15 to calving. Cows were segregated into 1 of 24 feeding pens three times weekly and received treatments individually from d 0 to calving. Calves were weaned on d 290 of the experiment, preconditioned for 35 d (d 291 to 325), and transferred to a feedyard where they remained until slaughter (d 514). Cows receiving CSSO and their calves had greater (P < 0.01) plasma concentrations of linoleic acid and total ω-6 PUFA compared with CON after calving. Colostrum IgG and calf plasma IgG concentrations 24 h after birth were greater (P ≤ 0.02) in CSSO vs. CON cattle. Calves from CSSO cows had greater (P ≤ 0.05) expression of adipogenic (adipocyte fatty acid-binding protein and stearoyl-CoA desaturase) and myogenic (myogenic differentiation 1 and myogenin) genes in the longissimus muscle (LM) compared with CON. No treatments differences in birth BW, weaning BW, and final preconditioning BW were noted (P ≥ 0.36). Average daily gain and final BW in the feedyard were greater (P ≤ 0.05) in steers from CSSO cows compared with CON. The incidence of calves diagnosed with BRD that required a second antimicrobial treatment was less (P = 0.03) in calves from CSSO cows, resulting in reduced (P = 0.05) need of treatments to regain health compared with CON. Upon slaughter, LM area was greater (P = 0.03) in calves from CSSO cows compared with CON. Collectively, these results are indicative of programming effects on postnatal offspring growth and health resultant from CSSO supplementation to late-gestating cows. Hence, supplementing CSSO to beef cows during pregnancy might be a feasible alternative to optimize offspring productivity and welfare.
This experiment investigated the effects of 24-h feed or water deprivation on hay intake, metabolic, and inflammatory responses in growing beef heifers. Forty Angus × Hereford heifers were ranked by initial BW (275 ± 6 kg) and age (278 ± 6 d) and randomly allocated to 20 drylot pens (2 heifers/pen). Pens were randomly assigned to 1 of 5 squares (4 × 4; 4 pens/square; a total of 8 animals per square), that were run simultaneously with each containing 4 experimental periods of 17 d each (day −6 to 10). From day −5 to 0 of each period, pens were offered alfalfa-grass hay ad libitum + 454 g of dried distillers grains with solubles (as-fed basis) per heifer daily. On day 0 of each period, pens received 1 of 4 treatments: 1) feed and water deprivation for 24 h (FWD), 2) feed deprivation for 24 h, but regular access to water (FD), 3) water deprivation for 24 h, but regular access to feed (WD), or 4) regular access to feed and water (CON). Treatments were concurrently applied from day 0 to 1. Heifer full BW was collected on day −6 and −5, before (day 0) and after (day 1) treatment application, and on day 3, 6, 9, and 10 of each period. Hay DMI was recorded daily from day −5 to 10. Blood samples were collected on day −5, 0, 1, 3, 6, and 10 of each experimental period. Following treatment application on day 1, BW loss was greater, and BW was less (P < 0.01) in WD, FWD, and FD compared with CON heifers, and similar (P = 0.64) among FWD and FD heifers. No treatment effects were detected (P ≥ 0.21) for final BW and overall ADG. Plasma cortisol concentrations were greater (P < 0.01) in FD and FWD vs. WD and CON on day 1, whereas FD had greater (P < 0.01) plasma cortisol concentration vs. CON, WD, and FWD on day 6 and 10. Serum NEFA concentration was greater (P < 0.01) in FD and FWD vs. WD and CON on day 1, and greater (P < 0.01) in WD vs. CON heifers on day 1. No treatment effects were detected (P = 0.53) for plasma haptoglobin concentration. Plasma ceruloplasmin concentration was greater (P < 0.01) in FD and FWD vs. CON on day 1, and greater (P < 0.01) in FD vs. CON and WD on day 3 and 6. Collectively, feed or water deprivation for 24 h did not impact feed intake and BW gain, whereas metabolic results suggest that feed deprivation stimulates cortisol, NEFA, and ceruloplasmin responses in growing beef heifers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.